Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas - Merlo, A; Hausmann, O; Wasner, M (Clin Cancer Res, 1999)
et al.